Skip to main content
. 2014 Dec;14(4):802–809. doi: 10.4314/ahs.v14i4.5

Table 3.

Sensitivity profile of bacterial isolates from Surgical Wound infections

Organism No of
Isolates
No of isolates resistant (%)

Chl Cip Of Ery. PV. PP. CE DX TR FU TM
S. aureus 20 7(35.0) 0 0 14(70.0) 20(100) 20(100) 19(95.0) 18 (90.0) 18 (90.0) 9 (45.0) 9(45.0)
CoNS 11 6(54.5) 1(9.1) 0 10(90.9) 11(100) 11(100) 11(100) 11(100) 11(100) 9 (81.8) 9(81.8)
Bacillus spp 14 5(35.7) 5(35.7) 4(28.6) 14(100) 14(100) 14(100) 14(100) 14(100) 8(57.1) 11(78.6) 7(50.0)
Enterococcus spp 3 1(33.3) 1(33.3) 1(33.3) 1(33.3) 2(66.7) 2(66.7) 2(66.7) 2(66.7) 2(66.7) 2(66.7) 1(33.3)
Enterobacter 4 1(25.0) 1(25.0) 2(50.0) 3(75.0) 4(100) 4(100) 4(100) 4(100) 4(100) 4(100) 2(50.0)
E. coli 13 5(38.5) 2(15.4) 6(46.2) 10(76.9) 13(100) 13(100) 13(100) 13(100) 13(100) 8(61.5) 4(30.8)
K. pneumonia 2 1(50.0) 1(50.0) 2(100) 1(50.0) 2(100) 2(100) 2(100) 2(100) 2(100) 2(100) 1(50)
Proteus spp 5 4(80.0) 2(40.0) 4(80.0) 4(80.0) 5(100) 5(100) 5(100) 4(80.0) 4(80.0) 4(80.0) 4(80.0)
Citrobacter spp 1 0 0 0 0 0 0 0 0 0 0 0
Serratia odorifera 6 4(66.7) 2(33.3) 4(66.7) 4(66.7) 6(100) 6(100) 6(100) 6(100) 4(66.7) 4(66.7) 3(50.0)
Ps. aeruginosa 14 4(28.6) 5(35.7) 8(57.1) 10(71.4) 14(100) 14(100) 14(100) 11(78.6) 8(57.1) 10(71.4) 4(28.6)
Pseudomonas spp 8 4(50.0) 3(37.5) 4(50.0) 6(75.0) 8(100) 8(100) 8(100) 6(75.0) 3(37.5) 6(75.0) 4(50.0)
Bacteroides 5 3(60.0) 3(60.0) 3(60.0) 5(100) 5(100) 5(100) 5(100) 5(100) 3(60.0) 5(100) 3(60.0)
TOTAL 106 46(43.4) 27 (25.5) 39(36.8) 83(78.3) 105(99.1) 105(99.1) 104(98.1) 97(91.5) 81(76.4) 75(70.8) 52(49.1)

Ofloxaxin (Of), chloramphenicol (Chl), cephalothin (CE), erythromycin (Ery), ciprofloxacin (Cip), penicillin V (PV), Fusidic acid (FU), tobramycin (TM), Trimethoprim (TR), cefadroxil (DX), Piperacillin (PP).